Cluster and Registry trials Of the Working group of heart failure in Denmark - Are SPironolactone and Eplerenone Comparable Treatments? (CROWD-ASPECT)

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2022-502239-20-00

Enrollment

7200

Registered

2022-12-18

Start date

2023-01-01

Completion date

Unknown

Last updated

2024-04-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart failure

Brief summary

death

Detailed description

death or hospitalization for heart failure

Interventions

DRUGSpironolactone "Accord"

DRUGfilmovertrukne tabletter

DRUGEplerenon "Stada"

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Design outcomes

Primary

Measure	Time frame
death	—

Secondary

Measure	Time frame
death or hospitalization for heart failure	—

Countries

Denmark

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026